Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
抗CD166抗体、活性化可能抗CD166抗体、およびその使用方法
Document Type and Number:
Japanese Patent JP7028648
Kind Code:
B2
Abstract:
The invention relates generally to an-tibodies that bind CD166, activatable antibodies that specifically bind to CD 166 and methods of making and using these anti-CD166 antibodies and an-ti-CD166 activatable antibodies in a variety of thera-peutic, diagnostic and prophylactic indications.

Inventors:
West James William
Sagato Jason Gary
Terret Jonathan Alexander
Weaver Annie Young
Denoie Luc Roland
Shin Shuta
Application Number:
JP2017557287A
Publication Date:
March 02, 2022
Filing Date:
May 04, 2016
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
Cytomex Therapeutics Incorporated
International Classes:
C07K16/28; A61K9/00; A61K31/407; A61K31/551; A61K31/7036; A61K38/08; A61K39/395; A61K45/00; A61K47/65; A61K47/68; A61P35/00; A61P35/02; A61P35/04; C07K14/47; C07K19/00; C12N15/13; C12N15/63
Domestic Patent References:
JP2012514982A
Foreign References:
WO2014197612A1
WO2013163631A2
US20100233165
Other References:
Differentitation,2009年,Vol.77,p.256-262
Xenotransplantation,1999年,Vol.6,p.123-130
Journal of Cell Science,2005年,Vol.118, No.7,p.1515-1525
Cancer Immunology, Immunotherapy,2010年,Vol.59,p.1665-1674
Attorney, Agent or Firm:
Shimizu Hatsushi
Masao Haruna
Hirotaka Yamaguchi
Shun Jinbe
Ryuichi Inoue
Toshimitsu Sato
Koichi Niimi
Tomohiko Kobayashi
Hideki Kodera
Masato Ozeki
Kazuya Kawamoto